Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-115

This is a label for Mitomycin For Injection USP, including details such as dosage instructions, manufacturing information, and storage requirements. The label includes warnings about tissue damage and expiration dates for the solution.*

This is a description for a pharmaceutical product called Mitomycin. It comes in powder form and must be reconstituted with Sterile Water for Injection, USP before use. The product should be shaken until it dissolves, and each mL of the reconstituted solution will contain 40 mg of Mitomycin and 80 mg of mannitol. The administration of the product must be done intravenously to avoid tissue damage. The product must be stored at 25°C, with excursions permitted between 15°C and 30°C, and must be protected from light. Once the solution is reconstituted, it must be refrigerated between 2° and 6°C and discarded within 14 days if refrigerated or within 7 days if not refrigerated. The product is manufactured by Intas Pharmaceuticals Limited in India and distributed in the US by Accord Healthcare, Inc. The package insert should be consulted for complete prescribing information.*

This appears to be a label for a medication called Mitomycin, to be administered via injection. The label includes dosage instructions and warnings, as well as lot and expiration information.*